MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impact of COVID-19 in Parkinson disease: preliminary analysis from a survey performed in a Peruvian PD cohort.

E. Sarapura-Castro, D. Rivera-Asencios, M. Illanes-Manrique, A. Rivera-Valdivia, M. Inca-Martinez, K. Mejia-Rojas, J. Rios-Pinto, A. Medina-Colque, I. Cornejo-Herrera, E. Ochoa-Valle, C. Cosentino, I. Mata, M. Cornejo-Olivas (Lima, Peru)

Meeting: 2022 International Congress

Abstract Number: 272

Keywords: Non-motor Scales, Parkinson’s

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: To analyze the impact of COVID-19 in Parkinson cases and healthy controls from a Peruvian population.

Background: The COVID-19 pandemic have a profound impact affecting worldwide people´s lives. The stress caused by COVID-19 pandemic may has increased problems for patients with Parkinson Disease (PD). There are few data on effects of COVID-19 pandemic in motor and non-motor symptoms, perceptions and attitudes in Peruvian PD patients.

Method: Since May 2021, all participants, PD cases and healthy controls, recruited for a genetic association study in Peru were offered to complete an optional COVID19 impact survey developed by National Alzheimer’s coordinating Center. We analyze information provided by all respondents based on descriptive analysis.

Results: We analyzed a total of 115 COVID-19 surveys, 19 PD cases (median age 60.9 years, 13 men) and 96 healthy controls (median age 57.5 years, 32 men). A total of 4 PD cases and 29 healthy controls declared to have COVID-19 (p = 0.45, Fisher’s test). PD cases feel more worried than healthy controls about contracting COVID-19 (p = 0.004, Fisher’s test). PD cases feel more isolated than controls due to COVID-19 pandemic (p = 0.02, Fisher’s test). PD cases are less able than healthy controls to control important things in their lives (p = 0.02, Fisher’s test). PD-related symptoms worsened in the majority of PD cases (12/19 PD cases). The PD- related symptoms that worse more frequently were anxiety (82.3%), depression (71%), fatigue (66.7%) and sleep (61%).

Conclusion: There is not difference in the risk of contracting COVID-19 observed among cases and controls. Our results suggest the COVID-19 pandemic has affected Peruvian PD patients in many aspects, including PD-related symptoms especially non-motors symptoms.

References: 1. National Alzheimer’s coordinating Center. COVID19 impact survey. June, 2020

To cite this abstract in AMA style:

E. Sarapura-Castro, D. Rivera-Asencios, M. Illanes-Manrique, A. Rivera-Valdivia, M. Inca-Martinez, K. Mejia-Rojas, J. Rios-Pinto, A. Medina-Colque, I. Cornejo-Herrera, E. Ochoa-Valle, C. Cosentino, I. Mata, M. Cornejo-Olivas. Impact of COVID-19 in Parkinson disease: preliminary analysis from a survey performed in a Peruvian PD cohort. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/impact-of-covid-19-in-parkinson-disease-preliminary-analysis-from-a-survey-performed-in-a-peruvian-pd-cohort/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-covid-19-in-parkinson-disease-preliminary-analysis-from-a-survey-performed-in-a-peruvian-pd-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley